Zachary Verne joins Ethics Talk to discuss his article, coauthored with Dr Jeffrey Zabinski: “How Should We Expand Access to Psychedelics While Maintaining an Environment of Peace and Safety?”

Physicians are obligated to inform patients involved in a clinical trial that there is a chance of receiving a placebo, which can result in a deterioration of a medical condition.

Physicians are obligated to inform patients involved in a clinical trial that there is a chance of receiving a placebo, which can result in a deterioration of a medical condition.

Even if a placebo is safe, it should not be employed as a way of mollifying patients or glossing over underlying causes of illness.

This article examines widespread adoption of ketamine as a proxy for psychedelics.